Phebra is one of Australia’s largest privately-owned pharmaceutical groups, with a manufacturing facility in Sydney which develops, produces and markets critical medicines in Australia and across the world. Since 1993, Phebra has built a reputation for innovation, product development and manufacture of over 65 medicines in critical therapeutic disease areas such as cystic fibrosis, antidotes, diagnostics, oncology and pain. Being dynamic and innovative, Phebra collaborates with healthcare providers to research, develop and produce critical medicines to meet unmet needs.
| Website | http://www.phebra.com |
| Revenue | $30.4 million |
| Employees | 100 (78 on RocketReach) |
| Founded | 1993 |
| Address | 19 Orion Rd, Lane Cove West, New South Wales 2066, AU |
| Phone | +61 1800 720 020 |
| Fax | +61 2 9420 9177 |
| Technologies |
JavaScript
,
HTML
,
PHP
+10 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
| Competitors | ADM, Fresenius Kabi, Baxter International Inc., Bristol Myers Squibb, Mylan Belgium, Sandoz, Teva Pharmaceuticals, Amgen, Lilly India, Novartis +38 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Phebra Pty Ltd employee's phone or email?
The Phebra Pty Ltd annual revenue was $30.4 million in 2026.
Andre Vlok is the CEO of Phebra Pty Ltd.
78 people are employed at Phebra Pty Ltd.
Phebra Pty Ltd is based in Lane Cove West, New South Wales.
The NAICS codes for Phebra Pty Ltd are [325, 3254, 32, 32541].
The SIC codes for Phebra Pty Ltd are [283, 28].